Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial

Three infusions of 10 × 10<sup>6</sup> allo-hMSCs/kg improved motor function in mild-to-moderate PwP, while two infusions showed less improvement than placebo. To address this discrepancy, future studies should conduct functional potency assays to understand batch-to-batch variability affecting clinical efficacy. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-09-01
DOI
https://doi.org/10.1002/mds.70028
Citations
3
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
4.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial

Jerome G. Saltarrelli, Timothy M. Ellmore, Nikunj Satani, Shahnawaz Mohammad et al.
3 citations
Movement Disorders
Mesenchymal stem cell research
4.88
article

Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial

Jerome G. Saltarrelli, Timothy M. Ellmore, Nikunj Satani, Shahnawaz Mohammad, Sean I. Savitz, Elsa M. Rodarte, Mya C. Schiess, Juan De Luigi Lemus, Emily Tharp, T Thomas, Charles E. Green, Jessika Suescun, Christopher Adams, Marie Françoise Doursout, Vanessa Thyne, Rula Abuamouneh
article en
3 citations

Abstract

Three infusions of 10 × 10<sup>6</sup> allo-hMSCs/kg improved motor function in mild-to-moderate PwP, while two infusions showed less improvement than placebo. To address this discrepancy, future studies should conduct functional potency assays to understand batch-to-batch variability affecting clinical efficacy. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 40(12)
City College of New York (US), University of Washington (US), Centre for Movement Disorders (CA), The University of Texas Health Science Center (US)
Michael J. Fox Foundation for Parkinson's Research, University of Texas Health Science Center at Houston
Openalex Percentile: Top 5%
Mesenchymal stem cell research
4.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial — Jerome G. Saltarrelli, Timothy M. Ellmore, et al. · Movement Disorders (2025) | TGRS Research Map | TGRS